0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query current partnering questcor pharmaceuticals partnering deals alliances 2010 2017.Your search for "" gave back 1208746 results.
Japan Vilene Company, Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Vilene Company, Ltd - Strategy, SWOT and Corporate Finance...
MarketLine
October 2021
Price: USD 175.00
Vitro SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Vitro SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
January 2021
Price: USD 175.00
Pharmaceutical Deal Trends (2010–2015) and In-Depth Analysis of Recent Deal Activity Summary GBI Research’s latest report, "Pharmaceutical Deal...
CBR Pharma Insights
October 2015
Price: USD 2,995.00
Guala Closures SpA - Strategy, SWOT and Corporate Finance Report Summary Guala Closures SpA - Strategy, SWOT and Corporate Finance Report, is a...
MarketLine
January 2021
Price: USD 175.00
Allianz Partners - Strategy, SWOT and Corporate Finance Report Summary Allianz Partners - Strategy, SWOT and Corporate Finance Report, is a source of...
Catalog:
MarketLine
November 2021
Price: USD 175.00
Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Chemical Holdings Corporation - Strategy,...
Catalog:
MarketLine
January 2021
Price: USD 175.00
Western Midstream Partners LP - Strategy, SWOT and Corporate Finance Report Summary Western Midstream Partners LP - Strategy, SWOT and Corporate...
Catalog:
MarketLine
July 2021
Price: USD 175.00
RSA Insurance Group plc - Strategy, SWOT and Corporate Finance Report Summary RSA Insurance Group plc - Strategy, SWOT and Corporate Finance Report,...
Catalog:
MarketLine
August 2021
Price: USD 175.00
Rhino Resource Partners LP - Strategy, SWOT and Corporate Finance Report Summary Rhino Resource Partners LP - Strategy, SWOT and Corporate Finance...
MarketLine
January 2021
Price: USD 175.00
Alzheimer’s disease is the most common cause of dementia among older people. It is a devastating condition for those afflicted as well as their...
iGATE
July 2017
Price: USD 1,250.00
Tate and Lyle PLC - Strategy, SWOT and Corporate Finance Report Summary Tate & Lyle PLC - Strategy, SWOT and Corporate Finance Report, is a...
MarketLine
June 2021
Price: USD 175.00
Merck & Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Merck & Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a...
MarketLine
January 2021
Price: USD 175.00
Alliance Resource Partners LP - Strategy, SWOT and Corporate Finance Report Summary Alliance Resource Partners LP - Strategy, SWOT and Corporate...
MarketLine
November 2022
Price: USD 175.00
RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective This...
Catalog:
La Merie Publishing
September 2019
Price: USD 2,350.00
Beta Nerve Growth Factor (Beta NGF or NGF) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players,...
Catalog:
Global Markets Direct
February 2022
Price: USD 3,500.00
